Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Quadruple Neoplasms following Radiation Therapy for Congenital Bilateral Retinoblastoma.

Szymanski LJ, Sibug Saber ME, Kim JW, Go JL, Zada G, Rao N, Hurth KM.

Ocul Oncol Pathol. 2017 Dec;4(1):33-37. doi: 10.1159/000477410. Epub 2017 Jul 6.

PMID:
29344496
2.

Adenocarcinoma of the Retinal Pigment Epithelium Arising in Conjunction with Late Recurrence and Systemic Metastasis of Retinoblastoma.

Roelofs K, Kherani F, Russell L, Heathcote JG, Weis E.

Ocul Oncol Pathol. 2017 Nov;3(4):296-300. doi: 10.1159/000468523. Epub 2017 Apr 14.

PMID:
29344484
3.

SKP2 Activation by Thyroid Hormone Receptor β2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells.

Xu XL, Li Z, Liu A, Fan X, Hu DN, Qi DL, Chitty DW, Jia R, Qui J, Wang JQ, Sharaf J, Zou J, Weiss R, Huang H, Joseph WJ, Ng L, Rosen R, Shen B, Reid MW, Forrest D, Abramson DH, Singer S, Cobrinik D, Jhanwar SC.

Cancer Res. 2017 Dec 15;77(24):6838-6850. doi: 10.1158/0008-5472.CAN-16-3299. Epub 2017 Sep 28.

PMID:
28972075
4.

Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.

Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26394. Epub 2016 Dec 26.

PMID:
28019092
5.

Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.

Racher H, Soliman S, Argiropoulos B, Chan HS, Gallie BL, Perrier R, Matevski D, Rushlow D, Piovesan B, Shaikh F, MacDonald H, Corson TW.

Cancer Genet. 2016 Jul-Aug;209(7-8):359-63. doi: 10.1016/j.cancergen.2016.06.001. Epub 2016 Jun 3.

6.

Clinical Presentation and Genetic Paradigm of Diffuse Infiltrating Retinoblastoma: A Review.

Traine PG, Schedler KJ, Rodrigues EB.

Ocul Oncol Pathol. 2016 Apr;2(3):128-32. doi: 10.1159/000441528. Epub 2015 Nov 14. Review.

7.

Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California.

Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R.

Ocul Oncol Pathol. 2015 Dec;2(2):105-11. doi: 10.1159/000439593. Epub 2015 Nov 5.

8.

Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies.

Kohno S, Kitajima S, Sasaki N, Takahashi C.

World J Stem Cells. 2016 Apr 26;8(4):170-84. doi: 10.4252/wjsc.v8.i4.170. Review.

9.

Retinoblastoma in a pediatric oncology reference center in Southern Brazil.

Selistre SGA, Maestri MK, Santos-Silva P, Schüler-Faccini L, Guimarães LSP, Giacomazzi J, Evangelista Júnior MC, Ashton-Prolla P.

BMC Pediatr. 2016 Apr 3;16:48. doi: 10.1186/s12887-016-0579-9.

10.

Correlation of CD24 expression with histological grading and TNM staging of retinoblastoma.

Ishaq SM, Kehar SI, Zafar S, Hasan SF.

Pak J Med Sci. 2016 Jan-Feb;32(1):160-4. doi: 10.12669/pjms.321.8828.

11.

Personalized Cancer Risk Assessments for Space Radiation Exposures.

Locke PA, Weil MM.

Front Oncol. 2016 Feb 22;6:38. doi: 10.3389/fonc.2016.00038. eCollection 2016. Review.

12.

Simultaneous Low- and High-Grade Primary Leiomyosarcomas in Two Separate Organs in a Thirty-Year Survivor of Hereditary Retinoblastoma.

Moore K, Tawfik O, Hays A, Opole I.

Case Rep Oncol Med. 2015;2015:968567. doi: 10.1155/2015/968567. Epub 2015 Dec 30.

13.

Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.

Friedman DN, Chou JF, Oeffinger KC, Kleinerman RA, Ford JS, Sklar CA, Li Y, McCabe MS, Robison LL, Marr BP, Abramson DH, Dunkel IJ.

Cancer. 2016 Mar 1;122(5):773-81. doi: 10.1002/cncr.29704. Epub 2016 Jan 11.

14.

Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.

Lumbroso-Le Rouic L, Aerts I, Hajage D, Lévy-Gabriel C, Savignoni A, Algret N, Cassoux N, Bertozzi AI, Esteve M, Doz F, Desjardins L.

Eye (Lond). 2016 Jan;30(1):46-52. doi: 10.1038/eye.2015.179. Epub 2015 Oct 2.

15.

Psychosocial Outcomes in Adult Survivors of Retinoblastoma.

Ford JS, Chou JF, Sklar CA, Oeffinger KC, Novetsky Friedman D, McCabe M, Robison LL, Kleinerman RA, Li Y, Marr BP, Abramson DH, Dunkel IJ.

J Clin Oncol. 2015 Nov 1;33(31):3608-14. doi: 10.1200/JCO.2014.60.5733. Epub 2015 Sep 28.

16.

Risk definition and management strategies in retinoblastoma: current perspectives.

Ghassemi F, Khodabande A.

Clin Ophthalmol. 2015 Jun 8;9:985-94. doi: 10.2147/OPTH.S59828. eCollection 2015. Review.

17.

The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.

Stewart E, Federico S, Karlstrom A, Shelat A, Sablauer A, Pappo A, Dyer MA.

Dev Biol. 2016 Mar 15;411(2):287-293. doi: 10.1016/j.ydbio.2015.03.001. Epub 2015 Jun 9.

18.

Options for management of intra ocular tumors.

Lingam G.

Indian J Ophthalmol. 2015 Mar;63(3):204-10. doi: 10.4103/0301-4738.156913. Review.

19.

Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.

Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KE.

Ann Surg Oncol. 2015 Nov;22(12):3913-20. doi: 10.1245/s10434-015-4453-z. Epub 2015 Mar 6.

20.

Cognitive function and social attainment in adult survivors of retinoblastoma: a report from the St. Jude Lifetime Cohort Study.

Brinkman TM, Merchant TE, Li Z, Brennan R, Wilson M, Hoehn ME, Qaddoumi I, Phipps S, Srivastava D, Robison LL, Hudson MM, Krull KR.

Cancer. 2015 Jan 1;121(1):123-31. doi: 10.1002/cncr.28924. Epub 2014 Nov 24.

Supplemental Content

Support Center